Health Condition 1: M279- Disease of jaws, unspecified
Conditions
Interventions
Intervention1: subcutaneous injection of Teriparatide: Teriparatide is a recombinant parathyroid hormone 20 ug/day will be administered subcutaneously with modified insulin pen for 4 weeks after reduc
Sponsors
ALL INDIA INSTITUTE OF MEDICAL SCIENCES
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adult patients of either sex Age 18-60 years 2. ASA I or II 3. Patients of maxillofacial fracture including fracture mandible
Exclusion criteria
Exclusion criteria: 1. Age 60 years 2. Pregnant or lactating female 3. Hypercalcemia, pagetâ??s disease. 4. Malignant tumours 5. Patients earlier having radiation treatment. 6. Edentulous patients or patients with less than 50% of teeth.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.pain-VAS score 2.mobility of fracture segments-0-mobility present,1-no mobility 3.bite force-flexi force sensorTimepoint: 1.pain-preoperatively,post operatively 1st,2nd,4th,6th week 2.mobility of fracture segment-preoperatively and postoperatively 1st,4th,8th week 3.bite force-preoperatively and postoperatively 1st,2nd,4th,6th,8th,12th week | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.blood investigations-serum calcium,PTH,ALP 2.Radiological assessment-ortho pantamogramTimepoint: 1.blood investigations-preoperatively and postoperative 4th week 2.radiological assessment-preoperatively and postoperatively on 1st day, 4th week, 8th week and 12th week | — |
Countries
India
Contacts
Public ContactDR GIGI
AIIMS,jodhpur
Outcome results
None listed